ArticleLeukemia & lymphoma2021

Phase 1 study of belinostat (PXD-101) and bortezomib (Velcade, PS-341) in patients with relapsed or refractory acute leukemia and myelodysplastic syndrome.

Beata Holkova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.